Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy

BACKGROUND: The role of second-line chemotherapy in advanced biliary cancers (ABCs) has only recently been established in phase III randomized trial and the optimal selection of patients most likely to benefit from it remains challenging. METHODS: A cohort of 98 ABC treated second-line chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Salati, Massimiliano, Marcheselli, Luigi, Messina, Carlo, Merz, Valeria, Messina, Marco, Carotenuto, Pietro, Caputo, Francesco, Gelsomino, Fabio, Spallanzani, Andrea, Reggiani Bonetti, Luca, Caramaschi, Stefania, Luppi, Gabriele, Dominici, Massimo, Ghidini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906899/
https://www.ncbi.nlm.nih.gov/pubmed/35283642
http://dx.doi.org/10.2147/CMAR.S346235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906899/
https://www.ncbi.nlm.nih.gov/pubmed/35283642
http://dx.doi.org/10.2147/CMAR.S346235

Ejemplares similares